Trial Profile
Retrospective review of patients with metastatic colorectal cancer treated with bevacizumab-based first-line therapy in a real-life setting.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Oct 2015
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Fluorouracil; Folinic acid; Irinotecan; Oxaliplatin
- Indications Colorectal cancer
- Focus Therapeutic Use
- 07 Oct 2015 New trial record